Clinical Trials

Stomach Neoplasms

NCT06003998 2023-08-22

INTERACT-II

85 enrolled

Colorectal Neoplasms

NCT05099848 2023-08-15

A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma

21 enrolled

Carcinoma, Hepatocellular

NCT04962958 2023-06-22

Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

Carcinoma, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

NCT05886465 2023-06-02

HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 Trial

40 enrolled

Carcinoma, Hepatocellular

NCT05797883 2023-04-04

FOLFOX/FOLFIRI Containing Levofolinic Acid (Zuoyu ®) in the Treatment of Unresectable or Metastatic Colorectal Cancer

Colorectal Neoplasms

NCT05029973 2023-02-08

HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCC

Carcinoma, Hepatocellular

NCT03883802 2022-12-09

NeoFox

100 enrolled

Colonic Neoplasms

NCT05617430 2022-11-15

Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma

43 enrolled

Carcinoma, Hepatocellular

NCT05535647 2022-09-10

Second Line Therapy for Advanced Intrahepatic Cholangiocarcinoma

Cholangiocarcinoma

NCT05493332 2022-08-18

HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC

93 enrolled

Carcinoma, Hepatocellular

NCT02839343 2022-05-24

Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer

126 enrolled 12 charts

Pancreatic Adenocarcinoma

NCT03940131 2022-04-06

REPAN

Colorectal Neoplasms

NCT03939962 2022-01-26

Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma

Stomach Neoplasms

NCT04621370 2020-11-09

PRIME-RT

48 enrolled

Rectal Neoplasms

NCT04155671 2019-11-07

POF Versus FOLFOX Plus IP Paclitaxel in AGC

260 enrolled

Stomach Neoplasms

NCT01923987 2019-09-20

Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis

39 enrolled

Rectal Neoplasms

NCT02486601 2019-02-27

FOXAGAST

55 enrolled

Stomach Neoplasms

NCT03812783 2019-01-23

HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCC

100 enrolled

Carcinoma, Hepatocellular

NCT03377842 2017-12-19

Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal Cancer

100 enrolled

Colorectal Neoplasms

NCT03280407 2017-09-28

NEOLAR

124 enrolled

Intestinal Diseases, Intestinal Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT02215837 2016-05-24

Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer

40 enrolled

Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Neoplasms, Stomach Neoplasms

NCT02202928 2015-12-28

Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer

Digestive System Neoplasms, Gastrointestinal Diseases, Intestinal Neoplasms, Neoplasms, Colorectal Neoplasms

NCT02452853 2015-05-25

HR Combined With FOLFOX4 for HCC With PVTT

51 enrolled

Carcinoma, Hepatocellular

NCT00004206 2014-06-24

Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT02128425 2014-05-07

FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal Cancer

162 enrolled

Colorectal Neoplasms

NCT00813137 2009-12-08

FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal Cancer

120 enrolled

Colorectal Neoplasms

NCT00884767 2009-07-08

Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin

206 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Neurotoxicity Syndromes

NCT00006115 2009-01-13

Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer